Could co-infection with Anaplasma play a role in Borrelia-associated primary cutaneous marginal zone B-cell lymphomas?

Indian J Dermatol Venereol Leprol. 2016 Jan-Feb;82(1):81-4. doi: 10.4103/0378-6323.171011.

Authors

Serena Bonin¹, Giuseppe Stinco, Maria Martina Patriarca, Sara Trevisini, Nicola di Meo, Giusto Trevisan

Affiliation

¹ Department of Medical Sciences, Unit of Dermatology, University of Trieste, Trieste, Italy.

PMID: 26728821
DOI: 10.4103/0378-6323.171011

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anaplasma / pathogenicity
Anaplasmosis / complications*
Anaplasmosis / diagnosis
Anaplasmosis / drug therapy
Biopsy, Needle
Borrelia / pathogenicity
Borrelia Infections / complications*
Borrelia Infections / diagnosis
Borrelia Infections / drug therapy
Coinfection / complications*
Coinfection / diagnosis
Doxycycline / therapeutic use
Female
Follow-Up Studies
Humans
Immunohistochemistry
Lymphoma, B-Cell, Marginal Zone / etiology*
Lymphoma, B-Cell, Marginal Zone / pathology
Lymphoma, B-Cell, Marginal Zone / physiopathology
Male
Middle Aged
Recurrence
Risk Assessment
Sampling Studies
Skin Neoplasms / etiology*
Skin Neoplasms / pathology
Skin Neoplasms / physiopathology

Substances

Doxycycline